This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival
Molecular Cancer Open Access 19 October 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Welterlin V, Debecker A, Tschieb D, Zanetti C, Lange W, Hénon P . Improvement of clonality detection rate in multiple myeloma using fluorescent IgH PCR with different sets of primers. J Hematother Stem Cell Res 2000; 9: 983–991.
Verhagen OJ, Willemse MJ, Breunis WB, Wijkhuis AJ, Jacobs DC, Joosten SA et al. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 2000; 14: 1426–1435.
Van der Velden VH, Hochhaus A, Cazzaniga G, Szczepanski T, Gabert J, Van Dongen JJ . Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003; 17: 1013–1034.
Lebecque SG, Gearhart PJ . Boundaries of somatic mutation in rearranged immunoglobulin genes: 5′ boundary is near the promoter, and 3′ boundary is approximately 1kb from V(D)J gene. J Exp Med 1990; 172: 1717–1727.
Pfaffl MW, Horgan GW, Dempfle L . Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real time PCR. Nucleic Acids Res 2002; 30: e36.
Pilarski LM, Hipperson G, Seeberger K, Pruski E, Coupland RW, Belch AR . Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice. Blood 2000; 95: 1056–1065.
Ladetto M, Omede P, Sametti S, Donovan JW, Astolfi M, Drandi D et al. Real-time polymerase chain reaction in multiple myeloma: Quantitative analysis of tumor contamination of stem cell harvests. Exp Hematol 2002; 30: 529–536.
Fenk R, Ak M, Kobbe G, Steidl U, Arnold C, Korthals M et al. Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma. Haematologica 2004; 89: 557–566.
Acknowledgements
This work was supported by grants from the ‘Groupe Arpège’ and the ‘Conseil Régional d'Alsace’.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu).
Rights and permissions
About this article
Cite this article
Rimelen, V., Ferrand, C., Debecker, A. et al. Relative quantification of residual tumor cells by lightcycler real-time IgH PCR in autografted multiple myeloma patients. Leukemia 19, 492–495 (2005). https://doi.org/10.1038/sj.leu.2403620
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403620